The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer.   The once-daily pill, called daraxonrasib and manufactured by Revolution Medicines, will be sold...

Source: [The Hill](https://thehill.com/policy/healthcare/6052834-fda-approves-pancreatic-cancer-drug/)

Sponsored